[1] LOPEZ M, HOPPE B. History, epidemiology and regional diversities of urolithiasis[J]. Pediatr Nephrol,2010,25(1):49-59.
[2] TISELIUS H G. Epidemiology and medical management of stone disease[J]. BJU Int,2003,91(8):758-767.
[3] PAIS V J, CHEW B, SHAW O, et al. Percutaneous nephrolithotomy for removal of encrusted ureteral stents: a multicenter study[J]. J Endourol,2014,28(10):1188-1191.
[4] LEGEMATE J D, WIJNSTOK N J, MATSUDA T, et al. Characteristics and outcomes of ureteroscopic treatment in 2650 patients with impacted ureteral stones[J]. World J Urol,2017,35(10):1497-1506.
[5] WHITE W, KLEIN F. Five-year clinical experience with the Dornier Delta lithotriptor[J]. Urology,2006,68(1):28-32.
[6] WITJES J A, BRUINS H M, CATHOMAS R, et al. European Association of Urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines[J]. Eur Urol,2020, 79(1):82-104.
[7] WANG Y, ZHONG B, YANG X, et al. Comparison of the efficacy and safety of URSL, RPLU, and MPCNL for treatment of large upper impacted ureteral stones: a randomized controlled trial[J]. BMC Urol,2017,17(1):50.
[8] TURK C, PETRIK A, SARICA K, et al. EAU guidelines on interventional treatment for urolithiasis[J]. Eur Urol,2016,69(3):475-482.
[9] 马仲顺. 输尿管镜钬激光碎石术治疗输尿管结石效果分析[J]. 河南外科学杂志,2019,25(1):113-114.
[10] 周酉枫,汤春波,齐勇,等. 封堵取石导管在输尿管镜钬激光碎石术中的应用[J]. 中国医师进修杂志,2014,37(26):57-58. |
